Lidija Klampfer
- Oncology top 2%
- Cytokine Signaling Pathways and Interactions 15
- Cancer Cells and Metastasis 5
- Colorectal Cancer Treatments and Studies 5
- Immunology top 5%
- Cancer Research top 5%
- NF-κB Signaling Pathways 8
-
- Cancer Mechanisms and Therapy 5
- Molecular Biology top 5%
- PI3K/AKT/mTOR signaling in cancer 8
- Cell death mechanisms and regulation 6
-
- Liver physiology and pathology 7
- Co-authors
- Leonard H. AugenlichtPawan KalerJie HuangJ VilčekSenji ShirasawaTakehiko SasazukiStephen D. NimerJohn M. Mariadason
- Cited by
- OncologyImmunologyCancer Research
- Partner nations
- United StatesJapanFrance
In The Last Decade
Lidija Klampfer
47 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 116
- Oncology 1.2k
- Immunology 683
- Cancer Research 486
- Pathology and Forensic Medicine 462
- Molecular Biology 1.6k
Countries citing papers authored by Lidija Klampfer
This map shows the geographic impact of Lidija Klampfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lidija Klampfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lidija Klampfer more than expected).
Fields of papers citing papers by Lidija Klampfer
This network shows the impact of papers produced by Lidija Klampfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lidija Klampfer. The network helps show where Lidija Klampfer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lidija Klampfer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 2 | |
| 2 | 2015 | 30 | |
| 3 | 2014 | 62 | |
| 4 | 2014 | 29 | |
| 5 | 2012 | 44 | |
| 6 | 2011 | 236 | |
| 7 | 2010 | 70 | |
| 8 | 2009 | 211 | |
| 9 | 2009 | 117 | |
| 10 | 2008 | 370 | |
| 11 | 2007 | 27 | |
| 12 | 2007 | 82 | |
| 13 | 2007 | 110 | |
| 14 | 2006 | 150 | |
| 15 | 2006 | 2 | |
| 16 | 2004 | 45 | |
| 17 | 2004 | 156 | |
| 18 | 2003 | 15 | |
| 19 | 2003 | 60 | |
| 20 | 1999 | 28 |
About Lidija Klampfer
Lidija Klampfer is a scholar working on Oncology, Hepatology and Cancer Research, having authored 48 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (15 papers), PI3K/AKT/mTOR signaling in cancer (8 papers), NF-κB Signaling Pathways (8 papers), Liver physiology and pathology (7 papers), Cell death mechanisms and regulation (6 papers), Cancer Cells and Metastasis (5 papers), Cancer Mechanisms and Therapy (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). The work is most often cited by research in Oncology (1.2k citations), Immunology (683 citations) and Cancer Research (486 citations). Lidija Klampfer has collaborated with scholars based in United States, Japan and France. Frequent co-authors include Leonard H. Augenlicht, Pawan Kaler, Jie Huang, J Vilček, Senji Shirasawa, Takehiko Sasazuki, Stephen D. Nimer, John M. Mariadason, Hans‐Georg Wisniewski and Diego Arango. Their work appears in journals such as Journal of Biological Chemistry, Cancer Research, Oncotarget, Oncogene and Journal of Nutrition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.